Relationships with the drug industry: Build trust based on good science

BMJ 2009; 338 doi: (Published 04 February 2009) Cite this as: BMJ 2009;338:b234
  1. Scott Gottlieb, health policy analyst
  1. 1American Enterprise Unit, 1150 17th Street, NW, Washington, DC 20036, USA
  1. Scott.Gottlieb{at}

    The relationship between the drug industry, academia, healthcare professionals, and patients has reached an all time low and few doubt that it is in the interests of all parties to improve it. A recent report from the Royal College of Physicians attempts to define a path towards achieving a more productive relationship. Here we set out five contrasting views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it (doi:10.1136/bmj.b222, doi:10.1136/bmj.b211, doi:10.1136/bmj.b252, doi:10.1136/bmj.b232)

    Medical treatments are becoming increasingly more individual, with respect to both disease and patient. They are also becoming more complex, and precise diagnoses and close monitoring are needed to optimise …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial